Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Elderly patients have a higher risk of experiencing adverse drug events due to an age related increase in morbidity and medication use. Inappropriate or wrong medication use among elderly patients acutely admitted to hospitals is assumed to result in earlier contact to general practitioner, emergency departments and re-admissions if not corrected during hospital admission. It is therefore our hypothesis that a systematic medication review conducted by pharmacists and physicians specialized in pharmacology will increase time to first unscheduled physician contact (general practitioner, emergency departments, ambulatory care and re-admissions) after discharge from hospital from an average of 21days to 25 days. Further, the following secondary outcome parameters will be measured at discharge and within 3-month follow-up:
- length of in-hospital stay
- number of contacts to general practitioner 30 days after discharge, that resulted in medication changes
- number of re-admissions at 3-month
- number of death at 3-month
- number of contact to primary health care at 3-month
- patients self-experienced quality of health(EQ-5D) 3-month
| Condition | Intervention |
|---|---|
|
Elderly |
Other: Systematic medication review and advisory notes |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | The Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department. |
- Time to first unscheduled physician contact(general practitioner,emergency department, ambulatory care or re-admission to hospital) after discharge from the Orthopaedic Department [ Time Frame: January 2010 ] [ Designated as safety issue: No ]
- Admission time [ Time Frame: October 2009 ] [ Designated as safety issue: No ]
| Enrollment: | 108 |
| Study Start Date: | April 2009 |
| Study Completion Date: | April 2010 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Intervention
Systematic medication review
|
Other: Systematic medication review and advisory notes
Within 24 hours of admission a pharmacist retrieve medication histories from patients included in the intervention group. Medication histories will be obtained from - medical records, medication charts, patients electronical medication profile, interview with patients and if necessary contact to the patients general practitioner. The obtained medication history will be discussed with a physician specialized in pharmacology and an advisory note with suggested changes to the patients medication is added to the medical record. The orthopedic physicians are not obliged to follow the suggested changes
|
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age 65 years or older
- expected admission time of more than 24 hours
- acute admission
Exclusion Criteria:
- Psychotic patients
- Moribund patients
- Suicidal patients
Contacts and Locations| Denmark | |
| Regional hospital, Randers | |
| Randers, Central Denmark Region, Denmark, 8900 | |
| Principal Investigator: | Nielsen Lars Peter, Assoc. Prof. | Aarhus University Hospital, Denmark |
More Information
Publications:
| Responsible Party: | Marianne Lisby, Aarhus University Hospital |
| ClinicalTrials.gov Identifier: | NCT00738816 History of Changes |
| Other Study ID Numbers: | Klinfarm |
| Study First Received: | August 20, 2008 |
| Last Updated: | December 13, 2010 |
| Health Authority: | Denmark: Danish Dataprotection Agency Denmark: The Danish National Committee on Biomedical Research Ethics |
Keywords provided by University of Aarhus:
|
Medication review Patient Safety |
Drug Prescriptions Drug-use |
ClinicalTrials.gov processed this record on May 16, 2013